SLC2A11 and cancer: The expression of SLC2A11 is significantly positively correlated with TMB in most cancers, including PAAD, ACC, LUAD, THYM, GBM, SARC, STAD, CESC, BRCA, GBMLGG, STES, and HNSC, but negatively correlated with TMB in SKCM (Figure 15A).